Table 1 Study group demographics

Males

18 (51.4%)

7 (43.8%)

n.s.

Age median (median, range)

77 (70.9, 26–98)

76.5 (70.7, 31–99)

n.s.

Anticoagulation

yes

13 (37.1%)

6 (37.5%)

n.s.

Type of anticoagulation

n.s.

ASS

7 (20.0%)

3 (18.8%)

Clopidogrel

0 (0.0%)

0 (0.0%)

ASS+Clopid

1 (2.8%)

0 (0.0%)

VKA

2 (5.6%)

1 (6.7%)

NOAC

3 (8.5%)

2 (12.5%)

History of previous stroke

yes

6 (17.1%)

2 (12.5%)

n.s.

History of AF^a

yes

7 (20.0%)

3 (18.8%)

n.s.

CCI^b

n.s.

0–1

18 (51.4%)

9 (60.0%)

2–3

15 (42.8%)

6 (37.5%)

>3

2 (5.7%)

1 (6.7%)

Art.hypertension

yes

17 (48.5%)

10 (62.5%)

n.s.

Diabetes

yes

5 (14.2%)

3 (18.8%)

n.s.

Renal disease

yes

1 (2.8%)

1 (6.7%)

n.s.

Liver disease

yes

2 (5.7%)

2 (12.5%)

n.s.

Pulmonary disease

yes

4 (11.4%)

2 (12.5%)

n.s.

Myocardial infarct /heart failure

yes

8 (22.8%)

3 (18.8%)

n.s.

PVD^c

yes

3 (8.5%)

1 (6.7%)

n.s.

Cancer^d

yes

5 (14.2%)

2 (12.5%)

n.s.